Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06560047 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Danish Evaluation of Early Catheter Ablation for Atrial Fibrillation in Patients With Heart Failure

Study acronym: DanAblate-HF
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 5 to 6
    • Start date changed from estimate of Sep 1, 2024 to Aug 28, 2024
    v3
  2. Secondary endpoints: details revised at 2 of 13 entriesv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The DanAblate-HF trial will investigate whether early catheter ablation treatment for atrial fibrillation in patients with heart failure is superior to standard treatment.
Trial Details
NCT Number NCT06560047
Lead Sponsor Aalborg University Hospital
Collaborators: Rigshospitalet, Denmark, Odense University Hospital, Aarhus University Hospital, Zealand University Hospital, Herlev and Gentofte Hospital
Conditions
(from sponsor)		 Atrial Fibrillation, Heart Failure
Related terms Atrial Fibrillation, Heart Failure
Enrollment 1,616 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov